Berry Consultants Acquires ADDPLAN® Clinical Trial Simulation Software from ICON
Summary
AUSTIN, Texas--(BUSINESS WIRE)--Berry Consultants, LLC announced today that it has acquired ownership of ADDPLAN® software from ICON plc. ADDPLAN’s functionality includes modules for adaptive multiple comparison procedures, population enrichment designs, dose finding designs, and with the multiple comparison procedure and modeling (MCPMod) approach that complements Berry Consultants existing software FACTS (Fixed and Adaptive Clinical Trial Simulator). With this acquisition, Berry Consultants now provides biostatisticians a one-stop shop for a suite of software tools for adaptive clinical trial design and can accelerate development efforts going forward for both products. We employ world-renowned experts in Bayesian statistics and strive to set the standard for adaptive clinical trial design and analysis across all medical disciplines. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations.